ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Science Policy: NCAB Opposes Law Making Data Available Under FOIA; Individuals Encouraged To Send comments To OMB

March 19, 1999

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

Sole Source Negotiations

October 17, 1975